Autopsy report · NCT06501989

Study of 5-fluorouracil (5-FU) in Patients With Metastatic Colorectal Cancer

“Principal Investigator has left Inova”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

Inova Health Care Services

Sponsor type

University, hospital or other

Conditions

Metastatic Colorectal Cancer

Interventions

Biweekly 5-FLUOROURACIL (5-FU); Biweekly Modified FOLFOX6; Biweekly FOLFIRI; mFOLFOXIRI

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Surgical Field Bacterial Contamination in Primary Total Hip (THA) and Knee (TKA) Arthroplasty
  “Study principal investigator left the organization” (76% match in meaning)
• Blood Flow Restriction Training Following Glenoid Labral Repair
  “Principal Investigator left research facility.” (74% match in meaning)
• Psychometric Validation of the "Antillanisée" Version of the Mini Mental State Examination (MMSEa)
  “Departure of the Principal Investigator” (74% match in meaning)
• Staged Bilateral Carpal Tunnel Release: Which Side Hurts More?
  “The researcher and principal investigator working on this study left the institution.” (73% match in meaning)
• "Mon Parcours de Vie" Localized Breast Cancer: Announcement, Support, Information on the Disease and Treatments. Pilot Study to Assess the Value of Written Information Documents.
  “Principal Investigator's departure” (73% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.